Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

AIM/EKF stock hub

AIM/EKF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/EKFis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
107.6M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/EKF
In the news

Latest news · AIM/EKF

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.2
P25 12.9P50 16.9P75 23.5
Trailing P/E53.2
P25 15.9P50 22.9P75 35.8
ROE3.5
P25 -54.2P50 2.1P75 13.7
ROIC4.3
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/EKF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
232
Groups with data
11
Currency
GBP
Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
297
Employees Change
-6%
Employees Change Percent
-1.98
Enterprise value
GBX 96.5M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Medical Devices
Isin
GB0031509804
Last refreshed
2026-05-10
Market cap
GBX 107.6M
Price
GBX 25
Price currency
GBX
Rev Per Employee
173,616.16x
Sector
Healthcare
Sic
3845
Symbol
aim/EKF
Website
https://www.ekfdiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.97%
EV Earnings
45.5x
EV/EBIT
13.84x
EV/EBITDA
9.12x
EV/FCF
11.81x
EV/Sales
1.87x
FCF yield
7.6%
Forward P/E
15.23x
P/B ratio
1.53x
P/E ratio
53.2x
P/S ratio
2.09x
PE Ratio10 Y
27.71x
PE Ratio3 Y
27.87x
PE Ratio5 Y
32.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
13.53%
EBITDA Margin
19.7%
FCF margin
15.86%
Gross margin
51.35%
Gross Profit
GBX 26.5M
Gross Profit Growth
5.9%
Gross Profit Growth Q
11.96%
Gross Profit Growth3 Y
2.65%
Gross Profit Growth5 Y
1.09%
Net Income
GBX 2.1M
Net Income Growth
-66%
Net Income Growth Q
-95.74%
Net Income Growth Years
0%
Net Income Growth3 Y
-23.69%
Pretax Margin
13.74%
Profit Margin
4.12%
Profit Per Employee
GBX 7,145
Profitable Years
3
ROA
5.36
Roa5y
6.38
ROCE
9.47
ROE
3.53
Roe5y
4.81
ROIC
4.3
Roic5y
11.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
11.33%
Cagr15y
3.56%
Cagr1y
21.38%
Cagr20y
1.49%
Cagr3y
-1.69%
Cagr5y
-17.18%
Div CAGR3
0%
Div CAGR5
1.76%
EPS Growth
-65.84
EPS Growth Q
-96
EPS Growth Years
0
EPS Growth3 Y
-23.57
FCF Growth
-28.34%
FCF Growth Q
-25.73%
FCF Growth3 Y
5.71%
OCF Growth
-28.92%
OCF Growth Q
-17.34%
OCF Growth10 Y
-3.46%
OCF Growth3 Y
-5.95%
OCF Growth5 Y
21.22%
Revenue Growth
2.73x
Revenue Growth Q
5.38x
Revenue Growth Quarters
2x
Revenue Growth Years
1x
Revenue Growth3 Y
0.4x
Revenue Growth5 Y
-1.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
GBX 0.63
Assets
GBX 81.1M
Cash
GBX 13.7M
Current Assets
GBX 30.9M
Current Liabilities
GBX 7.4M
Debt
GBX 1.4M
Debt EBITDA
GBX 0.13
Debt Equity
GBX 0.02
Debt FCF
GBX 0.17
Equity
GBX 70.3M
Interest Coverage
45.31
Liabilities
GBX 10.9M
Long Term Assets
GBX 50.3M
Long Term Liabilities
GBX 3.4M
Net Cash
GBX 12.3M
Net Cash By Market Cap
GBX 11.43
Net Cash Growth
5.2%
Net Debt EBITDA
GBX -1.21
Net Debt Equity
GBX -0.18
Net Debt FCF
GBX -1.5
Tangible Book Value
GBX 43.2M
Tangible Book Value Per Share
GBX 0.1
WACC
7.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.16
Inventory Turnover
3.2
Net Working Capital
GBX 10.2M
Quick ratio
2.66
Working Capital
GBX 23.5M
Working Capital Turnover
GBX 2.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
1.19%
Dividend per share
GBX 0
Last Dividend
GBX 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
192.45%
1Y total return
21.36%
200-day SMA
26.58
3Y total return
-4.98%
50-day SMA
25.09
50-day SMA vs 200-day SMA
50under200
5Y total return
-61.04%
All Time High
86.8
All Time High Change
-71.2%
All Time High Date
2021-09-14
All Time Low
6
All Time Low Change
316.67%
All Time Low Date
2003-06-04
ATR
1.25
Beta
0.53
Beta1y
-0.19
Beta2y
0.09
Ch YTD
-5.3
High
26.5
High52
32
High52 Date
2025-09-08
High52ch
-21.88%
Low
25
Low52
19
Low52 Date
2025-05-13
Low52ch
31.58%
Ma50ch
-0.36%
Price vs 200-day SMA
-5.94%
RSI
48.05
RSI Monthly
45.27
RSI Weekly
47.78
Sharpe ratio
0.47x
Sortino ratio
0.94
Total Return
1.19%
Tr YTD
-5.3
Tr15y
68.93%
Tr1m
4.17%
Tr1w
-5.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
GBX 7M
Operating Income Growth
-2.5
Operating Income Growth Q
-5.01
Operating Income Growth3 Y
0.8
Operating Income Growth5 Y
12.56
Operating margin
13.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
348,489,765%
Net Borrowing
-510,000
Shares Insiders
0.54%
Shares Institutions
77.39%
Shares Out
430,503,112
Shares Qo Q
-1.6%
Shares Yo Y
-1.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
GBX 8.2M
Average Volume
174,812.4x
Bv Per Share
0.16
CAPEX
GBX -1.5M
Ch10y
115.1
Ch15y
24.22
Ch1m
4.17
Ch1w
-5.84
Ch1y
21.36
Ch20y
-1.22
Ch3y
-8.93
Ch5y
-64.49
Ch6m
-0.4
Change
-4.94%
Change From Open
-5.66
Close
26.3
Days Gap
0.76
Depreciation Amortization
3,182,000
Dollar Volume
2,603,350
Earnings Date
2026-06-16
EBIT
GBX 7M
EBITDA
GBX 10.2M
EPS
GBX 0
F Score
6
FCF
GBX 8.2M
FCF EV Yield
8.47x
FCF Per Share
GBX 0.02
Financing CF
-5,863,000
Fiscal Year End
December
Founded
1,990
Goodwill
24,136,000
Graham Number
12.972
Graham Upside
-48.11
Income Tax
GBX 4.6M
Investing CF
-2,338,000
Is Primary Listing
1
Last Earnings Date
2026-03-24
Last Report Date
2025-12-31
Lynch Fair Value
GBX 2.35
Lynch Upside
-90.6
Ma150
25.66
Ma150ch
-2.56%
Ma20
25.2
Ma20ch
-0.78%
Net CF
1,533,000
Next Earnings Date
2026-06-16
Open
26.5
P FCF Ratio
13.16
P OCF Ratio
11.09
Position In Range
0
Ppne
22,299,000
Price Date
2026-05-08
Price EBITDA
GBX 10.59
Ptbv Ratio
2.49
Relative Volume
0.61x
Revenue
51,564,000x
SBC By Revenue
0.03x
Share Based Comp
14,000
Tax By Revenue
8.83x
Tax Rate
64.28%
Tr20y
34.32%
Tr6m
-0.4%
Volume
104,134
Z Score
8.51
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/EKF pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/EKF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+21.4%
S&P 500 1Y: n/a
3Y total return
-5.0%
S&P 500 3Y: n/a
5Y total return
-61.0%
S&P 500 5Y: n/a
10Y total return
+192.4%
S&P 500 10Y: n/a
Ownership

Who owns AIM/EKF?

Insider, institutional, and short-interest positioning.

Institutional ownership
+77.4%
Share of float held by funds and institutions
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.2%
Negative means the company is buying back shares.
Technical

AIM/EKF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
48.1
Neutral momentum band
Price vs 200-day MA
-5.9%
50/200-day relationship not available
Beta (5Y)
0.53
Less volatile than the market
Sharpe ratio
0.47
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/EKF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/EKF stock rating?

aim/EKF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/EKF analysis?

The full report lives at /stocks/aim/EKF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/EKF?

The latest report frames aim/EKF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/EKF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.